"delicate skin" "hyper-reactive skin"
Conditions
Interventions
None listed
Sponsors
Philips Research
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 65 years Willing to give a written informed consent Skin type II or III (Fitzpatrick scale)
Exclusion criteria
Exclusion criteria: Diagnosis of histamine hypersensitivity Diagnosis of silver allergy Presence of cardiac pacemakers or other implanted electric devices Pregnancy or lactation Atopic predisposition (i.e. history of allergic rhinitis or allergic conjunctivitis, atopic or contact dermatitis, hay fever, asthma) Any skin disease, including possible lesions found during screening Any bleeding disorder Use of immunosuppressive drugs (NSAIDs; biologicals; topical or systemic corticosteroids) Use of antihistamines drugs Increased risk to develop hypertrophic scars
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study endpoint consists in gaining insights into the differences in the average responses to histamine, both topically and iontophoretically applied, in sensitive and non-sensitive skin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands
Outcome results
None listed